Search results for: COVID-19 Research
Filter search results
Sarin KC
4 September 2024
…supported the institutionalisation of HTA in several countries including Bhutan, Ghana, and India. During the COVID-19 pandemic, his work focused on strengthening the use of infectious disease modelling for urgent…
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…timely diagnosis of HF. The use of point-of-care devices, notably, has been valuable during the COVID-19 pandemic by enabling real-time monitoring of HF patients. The information generated by these devices,…
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…seasonal adult vaccination programmes (e.g. against flu or COVID-19) that deliver protection within weeks after administration. What causes suboptimal vaccine policies? Three barriers stand in the way: Reactive healthcare systems:…
International Drug Pricing Transparency
20 July 2020, 11:00pm
…current pandemic, the cost of developing and manufacturing new interventions to treat or prevent the spread of COVID-19, and the factors driving their prices are under the public eye so…
OHE Annual Lecture 2022 | Universal Health Coverage: More Than Just Old Wine in a New Bottle?
6 October 2022, 6:00pm
…and new approaches in order to draw some lessons that were learned. To the extent possible, the implications of the COVID-19 pandemic for the attainment of UHC goals will also…
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
1 November 2021
…result of the COVID-19 pandemic. Legislative changes such as ‘presumed consent’, which requires individuals to ‘opt out’ of automatic organ donation, are seeking to increase the number of organs donated…
The NICE Health Technology Evaluation Manual: A Fresh Perspective Needed?
16 March 2022
…a world facing many challenges – from the devasting effect of COVID-19 on health systems worldwide to climate change and political instability. How we allocate public sector resources to address…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…areas – for example the mRNA technology that underpins some of the successful Covid-19 vaccines was developed for use in cancer. Reductions in the total size of the industry will…
The CBO Doesn’t Understand Investors
13 September 2021
…have adverse consequences for population health—both in the US and globally. In the face of rapid scientific progress, such as we have seen with the development of COVID-19 vaccines and…